Brain Tumors Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about Brain Tumors clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting

Construction of AI Model for Precision Imaging Diagnosis of Cranial Diseases

Cranial Diseases (e.g., Brain Tumors, Stroke, Neurodegenerative Disorders)
Tongji Hospital1,000 enrolled1 locationNCT07446842
Recruiting
Not Applicable

SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence

Brain Tumors
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta200 enrolled2 locationsNCT06878469
Recruiting
Phase 3

Short Versus Long-term Levetiracetam in Brain Tumors

SeizuresBrain TumorsAntiepileptics+1 more
Tata Memorial Centre604 enrolled2 locationsNCT06442748
Recruiting

Clinical Significance of Liquid Biopsy in Brain Tumor Patients: a 5-ALA Guided Approach

GlioblastomaGlioblastoma (GBM)Glioblastoma - Category+1 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta30 enrolled1 locationNCT07420543
Recruiting
Not Applicable

GenoDrugP 2025: Study on Three-dimensional Models Derived From Brain Tumors in Pediatric Patients

EpigeneticPediatric Brain TumorsGenomics
Meyer Children's Hospital IRCCS50 enrolled1 locationNCT07417072
Recruiting

Florida Center for Brain Tumor Research

Brain Tumors
University of Florida4,000 enrolled1 locationNCT00811148
Recruiting
Phase 1Phase 2

A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Malignant Brain Tumors

Malignant Brain Tumors
China Medical University Hospital10 enrolled2 locationsNCT07003139
Recruiting

Pediatric Radiation Therapy Registry

SarcomaPediatric Brain Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5,000 enrolled2 locationsNCT07129317
Recruiting
Not Applicable

Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors

MeningiomaDiffuse GliomaPituitary Adenoma+2 more
Tata Memorial Centre156 enrolled1 locationNCT06831461
Recruiting
Phase 1

Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 Mutation

Malignant Brain Tumors
Haisco Pharmaceutical Group Co., Ltd.159 enrolled6 locationsNCT07158710
Recruiting

A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma

Primary Malignant Brain Tumors
National Health Research Institutes, Taiwan250 enrolled8 locationsNCT05622409
Recruiting

A Vision-Language Foundation Model for Brain Disease Diagnosis From Multimodal Data

Brain DiseasesNeuro-Degenerative DiseaseBrain (Nervous System) Cancers+3 more
Xiangya Hospital of Central South University100,000 enrolled1 locationNCT07126821
Recruiting

Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline

GliomaBrain TumorsMedulloblastoma+1 more
Tata Memorial Centre200 enrolled1 locationNCT06779487
Recruiting
Not Applicable

Comparison of Proton and Photon Radiotherapy of Brain Tumors (ProtoChoice-Hirn)

Brain Tumors
Technische Universität Dresden555 enrolled2 locationsNCT02824731
Recruiting
Not Applicable

Brain Areas of Time-To-Contact Perception: an Awake Surgery Study

Brain Tumors
University Hospital, Toulouse240 enrolled1 locationNCT04128306